We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
Insulet
PODD
$10.3B
| $10.3M | 0.01% |
67,714
+56,475
| +502% | +$9.41M |
2025 Q4
2 quarters
|
|
1002
CALL
Coinbase
COIN
$42.8B
| $10.2M | 0.01% |
69,800
-9,100
| -12% | -$1.64M |
2023 Q3
11 quarters
|
|
1003
Shell
SHEL
$299B
| $10.2M | 0.01% |
131,161
+127,637
| +3,622% | +$11M |
2023 Q1
13 quarters
|
|
1004
Primo Brands
PRMB
$6.99B
| $10.2M | 0.01% |
415,527
+388,599
| +1,443% | +$8.62M |
2025 Q1
5 quarters
|
|
1005
Haemonetics
HAE
$5.38B
| $10.1M | 0.01% |
+134,981
| New | +$8.67M |
2026 Q2
0 quarters
|
|
1006
CALL
Booking.com
BKNG
$111B
| $10M | 0.01% |
56,100
-23,900
| -30% | -$4.08M |
2025 Q3
3 quarters
|
|
1007
iShares MSCI India ETF
INDA
$5.74B
| $10M | 0.01% |
+202,389
| New | +$9.9M |
2026 Q2
0 quarters
|
|
1008
PUT
Honeywell
HON
$69.5B
| $10M | 0.01% |
44,600
+15,900
| +55% | +$3.55M |
2023 Q4
10 quarters
|
|
1009
CALL
Delta Air Lines
DAL
$52.9B
| $10M | 0.01% |
106,400
-35,000
| -25% | -$2.64M |
2025 Q2
4 quarters
|
|
1010
CALL
Commault Systems
CVLT
$6.9B
| $10M | 0.01% |
+70,300
| New | +$7.55M |
2026 Q2
0 quarters
|
|
1011
National Health Investors
NHI
$3.23B
| $9.9M | 0.01% |
+130,123
| New | +$10M |
2026 Q2
0 quarters
|
|
1012
SBA Communications
SBAC
$19.6B
| $9.9M | 0.01% |
55,892
+54,302
| +3,415% | +$11.2M |
2025 Q1
5 quarters
|
|
1013
FIGS
FIGS
$3.43B
| $9.9M | 0.01% |
+963,651
| New | +$12.7M |
2026 Q2
0 quarters
|
|
1014
CALL
Nexstar Media Group
NXST
$5.07B
| $9.8M | 0.01% |
55,000
| – | – |
2026 Q1
1 quarter
|
|
1015
Acadia Pharmaceuticals
ACAD
$3.5B
| $9.8M | 0.01% |
388,024
+75,042
| +24% | +$1.65M |
2026 Q1
1 quarter
|
|
1016
Solaris Energy Infrastructure
SEI
$4.54B
| $9.8M | 0.01% |
121,598
-165,573
| -58% | -$11.8M |
2025 Q4
2 quarters
|
|
1017
Pagaya Technologies
PGY
$1.71B
| $9.8M | 0.01% |
535,780
+251,479
| +88% | +$3.57M |
2024 Q3
7 quarters
|
|
1018
PUT
Cloudflare
NET
$113B
| $9.7M | 0.01% |
+39,600
| New | +$8.66M |
2026 Q2
0 quarters
|
|
1019
CleanSpark
CLSK
$2.2B
| $9.7M | 0.01% |
+666,268
| New | +$9.4M |
2026 Q2
0 quarters
|
|
1020
CALL
McDonald's
MCD
$177B
| $9.7M | 0.01% |
35,800
-24,600
| -41% | -$7.05M |
2023 Q3
11 quarters
|
|
1021
Core & Main
CNM
$7.76B
| $9.6M | 0.01% |
199,699
-538,990
| -73% | -$26.6M |
2024 Q3
7 quarters
|
|
1022
CALL
Capital One
COF
$126B
| $9.6M | 0.01% |
48,000
-84,000
| -64% | -$16.1M |
2024 Q3
7 quarters
|
|
1023
PUT
DELISTED
Nuvalent
NUVL
| $9.6M | 0.01% |
+77,800
| New | +$8.37M |
2026 Q2
0 quarters
|
|
1024
CALL
Ocular Therapeutix
OCUL
$1.6B
| $9.6M | 0.01% |
+975,200
| New | +$8.84M |
2026 Q2
0 quarters
|
|
1025
Jabil
JBL
$30B
| $9.5M | 0.01% |
24,729
-346,782
| -93% | -$120M |
2025 Q4
2 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.